NanoMedtrix, LLC (NMTx) has recently won multiple patents related to the engineering of nanoparticles for imaging/detection (non-invisibly/remote) of cancer  (April 2024) and targeted drug delivery (August 2024). And one patent is allowed (September 2024) and pending related to various routes formulation for oral and intravesicular drug deliveries. 

Learn more about NanoMedtrix: https://nanomedtrix.com/about/